SavedAdd your journal

Journals / Çukurova Üniversitesi Tıp Fakültesi Dergisi / 1998 / Cilt: 23 - Sayı: 2

Prognosis of our cancer patients treated with palliative radiotherapy

Palyatif radyoterapi ile tedavi edllen kanser hastalarımızda prognoz

Erkut ERKURT
Candaş TUNALI
Pages
88–94
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a conclusion we observed that our all MO cancer patients had a better prognosis than all M1 cancer patients treated with palliative radiotherapy (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We retrospectively evaluated prognosis in 142 metastatic (M1) and 201 non-metastalic (MO) cancer patients treated with palliative radiotherapy (RT) between 1990 and 1995.- There was no statistically significant difference between M1 and MO cancer patients when sex, palliative radiotherapy (RT) programs, and age groups are taken into consideration.
📊
Key Findings & Data:But there was a statistically significant difference for primary tumor localizations and histologies (p2).
💡
Conclusion & Impact:As a conclusion we observed that our all MO cancer patients had a better prognosis than all M1 cancer patients treated with palliative radiotherapy (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

We retrospectively evaluated prognosis in 142 metastatic (M1) and 201 non-metastalic (MO) cancer patients treated with palliative radiotherapy (RT) between 1990 and 1995.- There was no statistically significant difference between M1 and MO cancer patients when sex, palliative radiotherapy (RT) programs, and age groups are taken into consideration. But there was a statistically significant difference for primary tumor localizations and histologies (p2). For the purpose of easy analysis various tumor types were roughly evaluated under two large histologie groups as epidermoid tumors (M1, 128 cases vr MO, 187 cases) and sarcomas (M1, 9 cases vr MO, 14 cases). Also analyses were done according to tumor localizations such as primary breast (M1, 27 cases vr MO, 13 cases), bladder (M1, 11 cases vr MO, 20 cases) and lung (M1, 46 cases vr MO, 77 cases) cancers. As a conclusion we observed that our all MO cancer patients had a better prognosis than all M1 cancer patients treated with palliative radiotherapy (p

Özet

1990-1995 yılları arasında, palyatif radyoterapi ile tedavi edilen, 142 metastatik (M1) ve 201 metastazsız (MÖ) kanser hastasının prognozu incelendi. M1 ile MÖ kanser hastaları arasında: cinsiyet, yaş ve radyoterapi (RT) program grupları dikkate alındığında, anlamlı farklılık bulunmamıştır (p>0.05); primer tümör yerleri/histolojileri açısından ise anlamlı fark saptanmıştır (p 2) göre sınıflandırıldı. Çok çeşitli tümör tipleri incelemeyi kolaylaştırmak amacıyla kabaca epidermoid tümörler (M1-128 olgu, MO-187 olgu), sarkomlar (M1-9 olgu, MO-14 olgu) adı altında iki grupta değerlendirildi. Ayrıca tümör yerleşimlerine göre, meme (M1-27 olgu, MO-13 olgu), mesane (M1-11 olgu, MO-20 olgu) ve bronş (M1-46 olgu, MO-77 olgu) kanserleri için de analizler yapıldı. Sonuç olarak, palyatif RT uygulanan, tüm MÖ hastalarımızın M1 hastalarımızdan daha iyi prognozlu olduğu gözlenmiştir (p

🔖

Cite This Article

ERKURT, E., TUNALI, C. (2022). Prognosis of our cancer patients treated with palliative radiotherapy. Çukurova Üniversitesi Tıp Fakültesi Dergisi, Cilt: 23 - Sayı: 2, 88–94. https://ajindex.com/articles/486254

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Arcangeli G, Micheli A, Arcangeli G, et al: The responsiveness of bone metastases to radiotherapy:The effect of site,histology and radiation dose on pain relief. Radiotherapy and Oncology 1989; 14, 95-101
  2. Ashby M: The role of radiotherapy in palliative care. J Pain Symptom Manage 1991; 6: 6, 380-8
  3. Beahrs OH, Hemon DH, Hutter RVP: Staging of Cancer American Joint Committe on Cancer, 4th ed., Philadelphia: JB Lippincott Co., 1993
  4. Capewell S, Sudlow MF: Performance and prognosis in patients with lung cancer. The Edinburgh Lung Cancer Group. Thorax 1990; 45: 12, 951-6
  5. Coia RL, Hanks EG, Martz K, et al: Practice patterns of palliative care for the United States 1984-1985. Int J Radiat Oncol Biol Phys 1988; 14, 1261-1269
  6. Correale JD, Monteverde DA, Bueri JA, et al: Craniocerebral involvement in lymphoma. Arq Neuropsiquiatr 1990; 48: 3, 306-14
  7. Fossa SD, Hosbach G: Short-term moderate-dose pelvic radiotherapy of advanced bladder carcinoma. A questionnaire-based evaluation of its symptomatic effect. Acta-Oncol 1991; 30: 6, 735-8
  8. Gridelli C, Perrone F, Gallo C, et al: Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two stage phase II study. EJC 1997; 33: 3, 392-397
  9. Henderson CI, Garber EJ, Breitmeyer BJ, et al: Comprehensive management of disseminated breast cancer. Cancer 1990; 66, 1439-1448
  10. Holmang S, Borghede G: Early complications and survival following short-term palliative radiotherapy in invasive bladder carcinoma. J Urol 1996; 155: 1, 100-2
  11. Holmes FA, Walters RS, Theriault RL, et al: Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. JNCI 1991; 83: 1797- 1805
  12. Hoskin JP, Crow J, Ford TH: The influence of extent and local management on the outcome of radiotherapy for brain metastases. Int J Radiat Oncol Biol Phys 1990; 19, 111-115
  13. Julka PK, Awasthy BS, Singh R, et al: Multimodal management of 200 cases of breast carcinoma: a retrospective analysis. Anti-Cancer Drugs 1995; 6: 2, 86
  14. Lawrence TS, Lichter AS. Soft Tissue Sarcomas in Perez CA, Brady LW (eds): Principles and Practice of Radiation Oncology, Philadelphia: JB Lippincott Co., 1992, p 1399-1412
  15. Maher EJ: The influence of national attitudes on the use of radiotherapy in advanced and metastatic cancer,with particular reference to differences between the United Kingdom and the United States of America:implications for future studies. In